Trikafta and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trikafta (elexacaftor, ivacaftor, tezacaftor; ivacaftor) and Ceftazidime (ceftazidime). Common drug interactions include increased appetite among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Trikafta and Ceftazidime. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Trikafta?

Trikafta has active ingredients of elexacaftor, ivacaftor, tezacaftor; ivacaftor. eHealthMe is studying from 11,852 Trikafta users. Check the latest studies of Trikafta.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

On Jul, 30, 2026

64 people who take Trikafta and Ceftazidime together, and have interactions are studied.

Trikafta and Ceftazidime drug interactions.

What are the common drug interactions of Trikafta and Ceftazidime, by gender? *:

female:

Increased appetite
Anxiety
Headache (pain in head)
Weight increased
Affective disorder (mental disorder)
Depressive symptom
Hypnopompic hallucination
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Panic attack
Sleep paralysis (waking up and unable to move or speak)

male:

Diarrhoea
Aspartate aminotransferase increased
Hospitalisation
Influenza
Pneumonia
Urinary tract infection
Chills (felling of cold)
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pyrexia (fever)

What are the common drug interactions of Trikafta and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

Pulmonary haemorrhage (acute bleeding from the lung)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
Premature baby

2-9:

n/a

10-19:

Anxiety
Affective disorder (mental disorder)
Depressive symptom
Hypnopompic hallucination
Panic attack
Sleep paralysis (waking up and unable to move or speak)
Suicidal ideation
Depressed mood
Emotional disorder
Increased appetite

20-29:

Acute respiratory distress syndrome
Acute respiratory failure
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Acne cystic (skin problems that cause pimples)
Pneumonia
Maternal exposure during pregnancy (use of substance during pregnancy)
Premature delivery

30-39:

Catheter site pain
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hospitalisation
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

40-49:

Cystic fibrosis (disease of the secretary glands)
Neoplasm malignant (cancer tumour)
Uterine cancer

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 53 people, 82.81%
Infection: 9 people, 14.06%

* Approximation only. Some reports may have incomplete information.

Do you take Trikafta and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously